Proteomic profiling and neurodegeneration in Alzheimer's disease - PubMed (original) (raw)
Proteomic profiling and neurodegeneration in Alzheimer's disease
T Tsuji et al. Neurochem Res. 2002 Oct.
Abstract
Quantitative proteome analysis of Alzheimer's disease (AD) brains was performed using 2-D gels to identify disease specific changes in protein expression. The task of characterizing the proteome and its components is now practically achievable because of the development and integration of four important tools: protein, EST, and complete genome sequence databases, mass spectrometry, matching software for protein sequences and protein separation technology. Mass spectrometry (MS) instrumentation has undergone a tremendous change over the past decade, culminating in the development of highly sensitive, robust instruments that can reliably analyze biomolecules, particularly proteins and peptides; we identified 35 proteins from over 100 protein spots on a 2-D gel. Using this current technology, protein-expression profiling, which is actually a specialized form of mining, is an important principal application of proteomics. The information obtained has tremendous potential as a means of determining the pathogenesis, and detecting disease markers and potential targets for drug therapy in AD.
Similar articles
- Proteome analysis of brain proteins in Alzheimer's disease: subproteomics following sequentially extracted protein preparation.
Shiozaki A, Tsuji T, Kohno R, Kawamata J, Uemura K, Teraoka H, Shimohama S. Shiozaki A, et al. J Alzheimers Dis. 2004 Jun;6(3):257-68. doi: 10.3233/jad-2004-6306. J Alzheimers Dis. 2004. PMID: 15201480 - Proteomics analysis in Alzheimer's disease: new insights into mechanisms of neurodegeneration.
Butterfield DA, Boyd-Kimball D. Butterfield DA, et al. Int Rev Neurobiol. 2004;61:159-88. doi: 10.1016/S0074-7742(04)61007-5. Int Rev Neurobiol. 2004. PMID: 15482815 Review. No abstract available. - Analysis of the proteomic profiling of brain tissue in Alzheimer's disease.
Tsuji T, Shimohama S. Tsuji T, et al. Dis Markers. 2001;17(4):247-57. doi: 10.1155/2001/386284. Dis Markers. 2001. PMID: 11790892 Free PMC article. - Proteomic analysis of oxidatively modified proteins in Alzheimer's disease brain: insights into neurodegeneration.
Butterfield DA, Castegna A. Butterfield DA, et al. Cell Mol Biol (Noisy-le-grand). 2003 Jul;49(5):747-51. Cell Mol Biol (Noisy-le-grand). 2003. PMID: 14528911 Review. - Olfactory bulb proteome dynamics during the progression of sporadic Alzheimer's disease: identification of common and distinct olfactory targets across Alzheimer-related co-pathologies.
Zelaya MV, Pérez-Valderrama E, de Morentin XM, Tuñon T, Ferrer I, Luquin MR, Fernandez-Irigoyen J, Santamaría E. Zelaya MV, et al. Oncotarget. 2015 Nov 24;6(37):39437-56. doi: 10.18632/oncotarget.6254. Oncotarget. 2015. PMID: 26517091 Free PMC article.
Cited by
- Sorcin in Cancer Development and Chemotherapeutic Drug Resistance.
Exertier C, Antonelli L, Fiorillo A, Bernardini R, Colotti B, Ilari A, Colotti G. Exertier C, et al. Cancers (Basel). 2024 Aug 9;16(16):2810. doi: 10.3390/cancers16162810. Cancers (Basel). 2024. PMID: 39199583 Free PMC article. Review. - Genetically Encoded ATP Biosensors for Direct Monitoring of Cellular ATP Dynamics.
White D 3rd, Yang Q. White D 3rd, et al. Cells. 2022 Jun 14;11(12):1920. doi: 10.3390/cells11121920. Cells. 2022. PMID: 35741049 Free PMC article. Review. - ATP Synthase and Mitochondrial Bioenergetics Dysfunction in Alzheimer's Disease.
Patro S, Ratna S, Yamamoto HA, Ebenezer AT, Ferguson DS, Kaur A, McIntyre BC, Snow R, Solesio ME. Patro S, et al. Int J Mol Sci. 2021 Oct 17;22(20):11185. doi: 10.3390/ijms222011185. Int J Mol Sci. 2021. PMID: 34681851 Free PMC article. Review. - Sorcin is an early marker of neurodegeneration, Ca2+ dysregulation and endoplasmic reticulum stress associated to neurodegenerative diseases.
Genovese I, Giamogante F, Barazzuol L, Battista T, Fiorillo A, Vicario M, D'Alessandro G, Cipriani R, Limatola C, Rossi D, Sorrentino V, Poser E, Mosca L, Squitieri F, Perluigi M, Arena A, van Petegem F, Tito C, Fazi F, Giorgi C, Calì T, Ilari A, Colotti G. Genovese I, et al. Cell Death Dis. 2020 Oct 15;11(10):861. doi: 10.1038/s41419-020-03063-y. Cell Death Dis. 2020. PMID: 33060591 Free PMC article.
References
- J Neurol Sci. 1999 Jul 1;166(2):100-6 - PubMed
- Eur J Pharmacol. 2001 Feb 9;413(1):11-29 - PubMed
- Mol Biol Med. 1988 Dec;5(3):167-72 - PubMed
- Nature. 1996 Feb 1;379(6564):466-9 - PubMed
- Electrophoresis. 1996 May;17(5):813-29 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous